ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Merck Announces Update on the INTR@PID Clinical Program Including Lung 037 Study
January 21, 2021Merck, a leading science and technology company, announced an update on the Phase III INTR@PID Lung 037 study and the extensive INTR@PID clinical trial program for the potential first-in-class investigational bifunctional immunotherapy bintrafusp alfa ...
Pharma Sources Insight January 2025
